首页 > 市场调查报告书 > 医疗设备

呼吸器

市场调查报告书

商品编码

1665346

膜氧合器市场机会、成长动力、产业趋势分析与 2025 - 2034 年预测

Membrane Oxygenators Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

出版日期: 2024年12月23日 | 出版商:

Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2024 年全球膜氧合器市场价值为 1.321 亿美元，预计 2025 年至 2034 年期间的复合年增长率为 2.2%。膜氧合器在生命维持中发挥着至关重要的作用，尤其是在重症监护情况下。此外，全球人口老化更容易受到这些情况的影响，这进一步加速了市场扩张。中空纤维膜等技术创新正在提高气体交换效率并促进整个医疗保健领域的采用。

从类型来看，中空纤维膜氧合器是高成长领域。预计该领域的复合年增长率为 2.6%，到 2034 年将产生 1.006 亿美元的收入。这些氧合器以其高效的气体交换和紧凑的设计而闻名，特别适合紧急情况下的体外膜氧合 (ECMO) 程序。它们适用于成人和儿科护理环境，巩固了其市场主导地位。

市场范围
起始年份	2024
预测年份	2025-2034
起始值	1.321亿美元
预测值	1.628 亿美元
复合年增长率	2.2%

在应用方面，呼吸系统领域持续展现出强劲的潜力，预计到 2034 年将达到 7,250 万美元，复合年增长率为 1.9%。慢性阻塞性肺病（COPD）和肺炎等呼吸系统疾病的发生率不断上升是需求的主要驱动因素。人口老化、空气污染水平不断升级以及烟草广泛使用等因素导致全球呼吸系统併发症增加，从而增加了对 ECMO 治疗和膜式氧合器的需求。

美国膜式氧合器市值在 2024 年将达到 4,420 万美元，预计到 2034 年将以 1.4% 的复合年增长率增长。人口老化加剧了慢性疾病的发生，进一步增加了对 ECMO 治疗的需求。便携式和高性能氧合器的创新，加上新生儿和儿科护理中先进生命维持系统的日益普及，是推动区域成长的其他因素。

产业生态系统分析
产业衝击力
- 成长动力
  - 心血管疾病盛行率上升
  - 体外膜氧合（ECMO）需求不断成长
  - 急性呼吸窘迫症候群（ARDS）发生率高
  - 器官移植手术增多
  - 儿科和新生儿护理应用激增
- 产业陷阱与挑战
  - 严格的监管要求
  - 先进氧合器成本高
成长潜力分析
监管格局
技术格局
差距分析
波特的分析
PESTEL 分析
未来市场趋势
价值链分析
体外膜氧合器（ECMO）的演变
人工智慧预测 ECMO 支持患者出血情况

第四章：竞争格局

介绍
公司矩阵分析
公司市占率分析
主要市场参与者的竞争分析
竞争定位矩阵
策略仪表板

第五章：市场估计与预测：按类型，2021 — 2034 年

主要趋势
中空纤维膜氧合器
平板膜氧合器

第六章：市场估计与预测：按应用，2021 — 2034 年

主要趋势
呼吸系统
- 呼吸衰竭
- 肺栓塞
- 急性呼吸窘迫症候群
- 肺炎
- 新冠肺炎
心臟
- 失代偿性心肌病变
- 急性心肌梗塞
- 心臟休克
- 移植后併发症
- 心肌炎
体外心肺復苏

第七章：市场估计与预测：依年龄段，2021 年至 2034 年

主要趋势
成年人
新生儿
儿科

第 8 章：市场估计与预测：依最终用途，2021 年至 2034 年

主要趋势
医院
门诊手术中心
其他最终用户

第九章：市场估计与预测：按地区，2021 年至 2034 年

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋

第十章：公司简介

Abbott
BRAILE
chalice
CytoSorbents
EUROSETS
Fresenius
GETINGE
LivaNova
Medtronic
MicroPort
NIPRO
PrecisionMedical
RECTUS MEDICAl
TERUMO
XENIOS

简介目录

Product Code: 12827

The Global Membrane Oxygenators Market, valued at USD 132.1 million in 2024, is poised for steady growth with a projected CAGR of 2.2% between 2025 and 2034. This growth is driven by the rising prevalence of respiratory and cardiac disorders, including acute respiratory distress syndrome (ARDS), cardiogenic shock, and myocarditis, which are fueling demand for advanced oxygenation systems. Membrane oxygenators play a vital role in life support, especially in critical care scenarios. Additionally, the aging global population, which is more vulnerable to these conditions, further accelerates market expansion. Technological innovations, such as the adoption of hollow fiber membranes, are enhancing gas exchange efficiency and boosting adoption across healthcare settings.

By type, hollow fiber membrane oxygenators stand out as a high-growth segment. Expected to grow at a CAGR of 2.6%, this segment is anticipated to generate USD 100.6 million by 2034. Known for their efficiency in gas exchange and compact design, these oxygenators are particularly suited for extracorporeal membrane oxygenation (ECMO) procedures in emergency situations. Their adaptability for use in both adult and pediatric care settings cements their market dominance.

Market Scope
Start Year	2024
Forecast Year	2025-2034
Start Value	$132.1 Million
Forecast Value	$162.8 Million
CAGR	2.2%

In terms of application, the respiratory segment continues to demonstrate strong potential, projected to reach USD 72.5 million by 2034 with a CAGR of 1.9%. The increasing incidence of respiratory conditions such as chronic obstructive pulmonary disease (COPD) and pneumonia is a key driver of demand. Factors like aging populations, escalating air pollution levels, and widespread tobacco use are contributing to a global rise in respiratory complications, heightening the need for ECMO therapy and membrane oxygenators.

The U.S. membrane oxygenators market, valued at USD 44.2 million in 2024, is expected to grow at a CAGR of 1.4% through 2034. The country's robust healthcare infrastructure and high prevalence of respiratory and cardiovascular diseases make it a significant contributor to market expansion. An aging population prone to chronic health conditions further bolsters demand for ECMO treatments. Innovations in portable and high-performance oxygenators, coupled with increasing adoption of advanced life-support systems in neonatal and pediatric care, are additional factors driving regional growth.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising cardiovascular disease prevalence
  - 3.2.1.2 Growing demand for extracorporeal membrane oxygenation (ECMO)
  - 3.2.1.3 High incidence of acute respiratory distress syndrome (ARDS)
  - 3.2.1.4 Rise in organ transplant procedures
  - 3.2.1.5 Surging application in pediatric and neonatal care
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 Strict regulatory requirements
  - 3.2.2.2 High costs of advanced oxygenators
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Gap analysis
3.7 Porter's analysis
3.8 PESTEL analysis
3.9 Future market trends
3.10 Value chain analysis
3.11 Evolution of extracorporeal membrane oxygenators (ECMO)
3.12 AI-enabled prediction of bleeding in patients supported on ECMO

Chapter 4 Competitive Landscape, 2024

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 — 2034 ($ Mn)

5.1 Key trends
5.2 Hollow fiber membrane oxygenators
5.3 Flat sheet membrane oxygenators

Chapter 6 Market Estimates and Forecast, By Application, 2021 — 2034 ($ Mn)

6.1 Key trends
6.2 Respiratory
- 6.2.1 Respiratory failure
- 6.2.2 Pulmonary embolism
- 6.2.3 Acute respiratory distress syndrome
- 6.2.4 Pneumonia
- 6.2.5 COVID-19
6.3 Cardiac
- 6.3.1 Decompensated cardiomyopathy
- 6.3.2 Acute myocardial infarction
- 6.3.3 Cardiogenic shock
- 6.3.4 Post-transplant complications
- 6.3.5 Myocarditis
6.4 Extra corporeal cardiopulmonary resuscitation

Chapter 7 Market Estimates and Forecast, By Age Group, 2021 — 2034 ($ Mn)

7.1 Key trends
7.2 Adults
7.3 Neonates
7.4 Pediatrics

Chapter 8 Market Estimates and Forecast, By End Use, 2021 — 2034 ($ Mn)

8.1 Key trends
8.2 Hospitals
8.3 Ambulatory surgical centers
8.4 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2021 — 2034 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE